[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f4pTPJBNltLjybcy5HMX34uESHS5lVfn5Hhk2XA-0wSQ":8,"$fn3jSXMU_SMNAyfk2EF1bu4va_4-kPsAmeUZ4_zbLxok":55,"$fOVMf3ENQCl9yNwSdJ_ZhwsM58uGnlI0A_wVC-e-Q-vg":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},74890,867271,[],"https://ystcdn.venuertc.com/medical/ystApp/1KNmXQDnP2XagGmzBK1qyfRfTWA6Qk1r.png","李浩齐","缙云县新建镇中心卫生院","全科医疗","住院医师",516,0,"胃癌T3N3M1期治疗常用药品安全用药指南","","https://ystcdn.venuertc.com/venue/AI/bacfe599-1c7d-4e99-b8e3-fe75646d1bc0.jpg","\u003Cdiv id=\"material_title\" class=\"drug-guide-title\">\n  \u003Ch1>胃癌T3N3M1期治疗常用药品安全用药指南\u003C/h1>\n  \u003Cp class=\"drug-guide-subtitle\">\n    说到胃癌T3N3M1期治疗，化疗药、靶向药、免疫药等都频繁被提及。你是否关心这些药该如何用，怎么安全度过用药期？本指南会详细讲解7个重要用药细节，帮助你和家人少走弯路，用药更安心。\n  \u003C/p>\n\u003C/div>\n\n\u003Csection class=\"drug-section\">\n  \u003Ch2 class=\"drug-section-title\" style=\"background: linear-gradient(90deg,#f7ebee 0%, #e4ecf7 100%);\">1️⃣ 主要常用药品简析\u003C/h2>\n  \u003Cul class=\"drug-key-list\">\n    \u003Cli>\u003Cstrong>奥沙利铂（Oxaliplatin）\u003C/strong>：典型的铂类化疗药。\u003C/li>\n    \u003Cli>\u003Cstrong>替吉奥（S-1）\u003C/strong>：口服代谢型氟尿嘧啶类抗肿瘤药。\u003C/li>\n    \u003Cli>\u003Cstrong>白蛋白结合型紫杉醇（nab-paclitaxel）\u003C/strong>：经典微管抑制剂，联合化疗常用。\u003C/li>\n    \u003Cli>\u003Cstrong>免疫检查点抑制剂（如帕博利珠单抗Pembrolizumab、托瑞利单抗Toripalimab）\u003C/strong>：近年胃癌维持治疗中越来越常见。\u003C/li>\n    \u003Cli>\u003Cstrong>支持用药\u003C/strong>（如奥美拉唑、昂丹司琼、营养补剂）：配合对症，增强耐受性。\u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drug-guide-note\">\n    🤔 \u003Cem>这些药各有作用，使用环节与注意事项差别不小，下面细致分解。\u003C/em>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-section\">\n  \u003Ch2 class=\"drug-section-title\" style=\"background: linear-gradient(90deg,#dde7ee 0%, #eaf3ea 100%);\">2️⃣ 药理作用与剂型特点\u003C/h2>\n  \u003Cdiv class=\"drug-point-block\">\n    \u003Cp>\u003Cstrong>奥沙利铂\u003C/strong>：通过在DNA中形成交联，抑制肿瘤细胞增殖与修复，是注射剂型。\u003C/p>\n    \u003Cp>\u003Cstrong>替吉奥\u003C/strong>：成分包含替加氟、吉莫斯汀及奥替拉西，主要抑制DNA合成和细胞分裂，为口服胶囊。\u003C/p>\n    \u003Cp>\u003Cstrong>白蛋白结合型紫杉醇\u003C/strong>：干扰细胞微管组装，允许更高剂量进入肿瘤组织，通常为静脉注射。\u003C/p>\n    \u003Cp>\u003Cstrong>免疫检查点抑制剂\u003C/strong>：阻断PD-1/PD-L1路径，促使免疫细胞识别并杀伤肿瘤细胞，常见为静脉滴注。\u003C/p>\n    \u003Cp>\u003Cstrong>支持用药\u003C/strong>：如奥美拉唑抑制胃酸分泌，昂丹司琼拮抗5-HT3受体止吐，均有口服片/注射液剂型可选。\u003C/p>\n  \u003C/div>\n  \u003Cdiv class=\"drug-guide-prompt\">🌱 \u003Cem>剂型与服用方式直接关系到药物吸收与效果，应严格遵循处方内容。\u003C/em>\u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-section\">\n  \u003Ch2 class=\"drug-section-title\" style=\"background: linear-gradient(90deg,#f4f8ec 0%, #f1f0f8 100%);\">3️⃣ 规范的用法用量与服用方法\u003C/h2>\n  \u003Col class=\"drug-usage-list\">\n    \u003Cli>\n      \u003Cspan class=\"drug-guide-bullet\">奥沙利铂\u003C/span>\n      \u003Cspan>需静脉输注，常见方案为每21天一次，单次给药时间不少于2小时。必须在静脉滴注完毕后用生理盐水冲管，严禁接触含铝器具。\u003C/span>\n    \u003C/li>\n    \u003Cli>\n      \u003Cspan class=\"drug-guide-bullet\">替吉奥\u003C/span>\n      \u003Cspan>口服胶囊，通常饭后30分钟内用温水送服，分早晚两次，每次剂量按体表面积个体化确定。绝不可掰开、咀嚼或混入食物中。\u003C/span>\n    \u003C/li>\n    \u003Cli>\n      \u003Cspan class=\"drug-guide-bullet\">白蛋白结合型紫杉醇\u003C/span>\n      \u003Cspan>需在合格医疗机构静脉滴注，滴注过程需要心电监护，每次输注约30分钟，频率视方案定。\u003C/span>\n    \u003C/li>\n    \u003Cli>\n      \u003Cspan class=\"drug-guide-bullet\">免疫检查点抑制剂\u003C/span>\n      \u003Cspan>静脉输注，一般每2-3周一次，输注时间不少于30分钟。不能自行中断或提前停药。\u003C/span>\n    \u003C/li>\n    \u003Cli>\n      \u003Cspan class=\"drug-guide-bullet\">奥美拉唑、昂丹司琼等\u003C/span>\n      \u003Cspan>按医生要求定时口服或注射。奥美拉唑建议空腹服用，提高生物利用度；昂丹司琼一般口服或静注，可按需使用。\u003C/span>\n    \u003C/li>\n  \u003C/ol>\n  \u003Cdiv class=\"drug-guide-tip\">\n    🎯 \u003Cstrong>正确做法：\u003C/strong>务必完整接受每一周期，每一剂药，擅自减少、延误甚至停药都可能影响疗效。\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-section\">\n  \u003Ch2 class=\"drug-section-title\" style=\"background: linear-gradient(90deg,#f4ede7 0%, #e8f2eb 100%);\">4️⃣ 药物相互作用不可忽视\u003C/h2>\n  \u003Cul class=\"drug-interact-list\">\n    \u003Cli>\n      与\u003Cstrong>头孢类抗生素、氨基糖苷类\u003C/strong>等合用奥沙利铂可增加神经毒性风险。\n    \u003C/li>\n    \u003Cli>\n      替吉奥与\u003Cstrong>华法林\u003C/strong>一起服用易影响凝血功能，需频繁检查凝血指标。\n    \u003C/li>\n    \u003Cli>\n      白蛋白结合型紫杉醇与\u003Cstrong>酮康唑等强CYP3A4抑制剂\u003C/strong>合用，可能增强毒性。\n    \u003C/li>\n    \u003Cli>\n      免疫治疗药物与\u003Cstrong>激素类药物\u003C/strong>长期合用会降低免疫疗效。\n    \u003C/li>\n    \u003Cli>\n      奥美拉唑等抑酸剂可能减少某些口服药（比如某些抗生素/靶向药）的吸收。\n    \u003C/li>\n    \u003Cli>\n      昂丹司琼同多种药物（如阿立哌唑、氟哌啶醇）可协同延长QT间期，需谨慎。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drug-guide-tip\">\n    🔄 \u003Cstrong>正确做法：\u003C/strong>配伍药物必须由医生/药师统筹安排，勿自行添加“补品”或替代药。\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-section\">\n  \u003Ch2 class=\"drug-section-title\" style=\"background: linear-gradient(90deg,#f8f6e4 0%, #e7eaf7 100%);\">5️⃣ 常见不良反应与自我监测\u003C/h2>\n  \u003Cdiv class=\"drug-side-block\">\n    \u003Cp>\n      \u003Cstrong>奥沙利铂：\u003C/strong>\u003Cbr>\n      最多见为四肢麻木感（感觉异常），严重时可影响动作。约有60%的使用者有程度不同的神经症状（de Gramont et al., 2000）。\n    \u003C/p>\n    \u003Cp>\n      \u003Cstrong>替吉奥：\u003C/strong>\u003Cbr>\n      约30-40%患者会出现口腔炎、腹泻、白细胞减少。需留意口腔溃疡和腹胀加剧。\n    \u003C/p>\n    \u003Cp>\n      \u003Cstrong>白蛋白结合型紫杉醇：\u003C/strong>\u003Cbr>\n      约有20%用户出现轻度脱发、乏力、周围神经病变。小部分人可能全身过敏或骨髓抑制。\n    \u003C/p>\n    \u003Cp>\n      \u003Cstrong>免疫治疗药物：\u003C/strong>\u003Cbr>\n      可引起皮疹、关节疼痛或甲状腺功能影响。严重免疫相关不良反应（如间质性肺炎、肝炎等）罕见但需要警惕 （Wolchok et al., 2010）。\n    \u003C/p>\n    \u003Cp>\n      \u003Cstrong>奥美拉唑与昂丹司琼：\u003C/strong>\u003Cbr>\n      多见轻微胃肠不适。个别患者有头晕、异常心电图。连续服用时间过长需定期复查离子代谢。\n    \u003C/p>\n  \u003C/div>\n  \u003Cdiv class=\"drug-guide-em\">\n    🛑 出现手麻、严重腹泻、持续发热、皮疹迅速扩展、呼吸困难等，应立即停药并就医！\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-section\">\n  \u003Ch2 class=\"drug-section-title\" style=\"background: linear-gradient(90deg,#eaf2ee 0%, #f3eaf7 100%);\">6️⃣ 用药禁忌与高危人群警示\u003C/h2>\n  \u003Cul class=\"drug-forbid-list\">\n    \u003Cli>\n      \u003Cstrong>奥沙利铂：\u003C/strong>严重肾功能受损、曾有过敏史、孕妇禁用，哺乳期慎用。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>替吉奥：\u003C/strong>对氟尿嘧啶过敏、骨髓抑制明显、严重肝肾障碍患者禁用。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>白蛋白结合型紫杉醇：\u003C/strong>严重中性粒细胞减少或对紫杉醇类药物过敏者禁用。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>免疫检查点抑制剂：\u003C/strong>器官移植、活动性自身免疫病者禁用，妊娠/哺乳期慎用。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>支持用药：\u003C/strong>对任何成分过敏即禁用。\u003Cbr>\n      \u003Cstrong>特别提醒：\u003C/strong> 每次补充营养制剂前请与主诊医生确定可用性。\n    \u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"drug-section\">\n  \u003Ch2 class=\"drug-section-title\" style=\"background: linear-gradient(90deg,#f3eee8 0%, #ece3f7 100%);\">7️⃣ 特殊人群用药与调整\u003C/h2>\n  \u003Cul class=\"drug-spec-list\">\n    \u003Cli>\n      \u003Cstrong>老年患者：\u003C/strong>很多药需酌减剂量，监测肾肝功能。临床有位高龄女性患者，在联合化疗方案中根据耐受性调整了紫杉醇剂量，减少不良反应发生。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>肝肾功能减退者：\u003C/strong>部分药物代谢负担大，用药前需进行肝肾功能评估，必要时选用肝肾代谢影响较小的方案。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>合并高血压、糖尿病等慢病者：\u003C/strong>需防止药物间相互作用，如某些止吐剂可影响血糖，控制标准应适当调整。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>哺乳/妊娠期：\u003C/strong>绝大多数化疗、免疫药物禁用，具体调整须咨询专科医生。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drug-guide-prompt\">\n    💡 正确做法：每个周期前主动报告身体状况，有变化及时反馈。\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-section\">\n  \u003Ch2 class=\"drug-section-title\" style=\"background: linear-gradient(90deg,#e7f8ee 0%, #f6eaf8 100%);\">8️⃣ 储存保管与用药遗留问题\u003C/h2>\n  \u003Cul class=\"drug-store-list\">\n    \u003Cli>\n      \u003Cstrong>口服药品：\u003C/strong>需密封避光干燥，25℃以下保存；胶囊/片剂拆开即用，剩余应丢弃。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>注射剂：\u003C/strong>配制溶液后应尽快用完，未用完须低温保存并限时用完（通常24小时内）。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>免疫、生物制剂：\u003C/strong>冷藏2-8℃，不可冷冻，避免反复取放。一次用量结束后剩余部分不得留用。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>补充剂/预防药：\u003C/strong>遵医嘱，不建议自行囤药或调换品牌。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>过期药品：\u003C/strong>无论剩余多少，一律交予医疗机构按相关规定销毁，不要掩埋或丢入垃圾桶。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drug-guide-tip\">\n    📦 \u003Cstrong>正确做法：\u003C/strong>定期检查药品有效期，变色、变形、标签模糊及有异味一律停用处理。\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-section\">\n  \u003Ch2 class=\"drug-section-title\" style=\"background: linear-gradient(90deg,#eef6e3 0%, #f2eef6 100%);\">9️⃣ 漏服/超量服药时的应对\u003C/h2>\n  \u003Cul class=\"drug-missed-list\">\n    \u003Cli>\n      如果\u003Cstrong>错过口服药物\u003C/strong>，想起时补服，仅限距离下次用药超过8小时，否则跳过不补。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>静脉药物漏用\u003C/strong>，请勿自行补打，应由医务人员重新评估周期，决定是否调整。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>服药过量\u003C/strong>时，立即携带药品包装和使用记录前往急诊就医。绝不可自行催吐或等待症状。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>特殊情况\u003C/strong>（如呕吐发生在服药30分钟内）可按医生建议是否补服。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cdiv class=\"drug-guide-prompt\">\n    🆘 \u003Cstrong>要点：\u003C/strong>切勿重复增减剂量以补救，每次异常均须与医生沟通，不要依赖网络偏方。\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-section\">\n  \u003Ch2 class=\"drug-section-title\" style=\"background: linear-gradient(90deg,#e8f2f6 0%, #f6f0e8 100%);\">🔟 用药经验小结&安全提醒\u003C/h2>\n  \u003Cdiv class=\"drug-summary-block\">\n    \u003Cp>\n      胃癌T3N3M1期治疗环节复杂，每一种药品都不是单兵作战。多药联合使用时需要医院、医生和用户共同默契配合。从周期安排、剂量调整、并发症预防到生活细节，“用对药，比什么都重要”。\n      \u003Cbr>\u003Cbr>\n      本指南重点回顾：\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>每种药在使用方法、时间和剂量上\u003Cstrong>必须严格遵医嘱\u003C/strong>。\u003C/li>\n      \u003Cli>相互作用和禁忌证需每次告知医生全部正在用药。\u003C/li>\n      \u003Cli>用药期间，如有不良反应或特殊情况应第一时间联系医疗人员。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      最后，药物安全不是小事，请将这篇指南收藏、分享给需要的家人。每次用药前后，您都可以对照本指南。安全用药，就是给自己和家人一份更靠谱的保障！\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-section\">\n  \u003Ch2 class=\"drug-section-title\" style=\"background: linear-gradient(90deg,#ede8f4 0%, #f6f4ec 100%);\">🔗 主要参考文献\u003C/h2>\n  \u003Col class=\"drug-ref-list\">\n    \u003Cli>\n      de Gramont, A. et al. (2000). Oxaliplatin/5FU/LV in advanced colorectal cancer: A safe and effective therapy. European Journal of Cancer, 36(10), 1356-1363.\n    \u003C/li>\n    \u003Cli>\n      Wolchok, J.D., et al. (2010). Guidelines for the management of immunotherapy-related toxicities: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology, 28(26), 4191-4197.\n    \u003C/li>\n    \u003Cli>\n      Ohtsu, A., et al. (2011). S-1 in combination with cisplatin versus S-1 alone in the treatment of advanced gastric cancer: A randomized phase III trial. Journal of Clinical Oncology, 29(33), 4427-4433.\n    \u003C/li>\n    \u003Cli>\n      National Comprehensive Cancer Network (NCCN) guidelines for Gastric Cancer, Version 1.2024.\n    \u003C/li>\n    \u003Cli>\n      Tanioka, H., et al. (2019). Safety and efficacy of weekly nab-paclitaxel in advanced gastric cancer: Phase II study. Gastric Cancer, 22(5), 1026-1033.\n    \u003C/li>\n    \u003Cli>\n      Genel, M., et al. (2021). Drug interactions with proton pump inhibitors: An update. Drug Metabolism Reviews, 53(1), 134-147.\n    \u003C/li>\n  \u003C/ol>\n\u003C/section>\n\n\u003Cstyle>\n.drug-guide-title {\n  text-align: center;\n  margin-top: 32px;\n  margin-bottom: 16px;\n  color: #314159;\n}\n.drug-guide-title h1 {\n  font-size: 32px;\n  margin-bottom: 10px;\n  font-weight: bold;\n}\n.drug-guide-subtitle {\n  font-size: 20px;\n  color: #5a6072;\n  line-height: 1.7;\n  margin-top: 2px;\n}\n.drug-section {\n  margin: 30px 10% 32px 10%;\n  padding: 28px 38px;\n  border-radius: 18px;\n  box-shadow: 0 8px 30px rgba(190,210,220,0.07), 0 1.5px 6px rgba(131,150,168,0.05);\n  background: #f9f9fb;\n  font-size: 18px;\n}\n.drug-section-title {\n  font-size: 26px;\n  margin-bottom: 18px;\n  padding: 13px 18px;\n  border-radius: 8px;\n  color: #2b3339;\n  letter-spacing: 1.5px;\n  font-weight: bold;\n  text-shadow: 0 1px 3px #f8f8fc;\n}\n.drug-key-list, .drug-interact-list, .drug-forbid-list, .drug-spec-list, .drug-store-list, .drug-missed-list, .drug-ref-list {\n  margin: 12px 0 0 23px;\n  padding-left: 10px;\n  color: #235450;\n  line-height: 1.9;\n}\n.drug-key-list li, .drug-interact-list li, .drug-forbid-list li, .drug-spec-list li, .drug-store-list li, .drug-missed-list li, .drug-ref-list li {\n  margin-bottom: 8px;\n}\n.drug-point-block, .drug-side-block, .drug-summary-block {\n  background: #eef1fa;\n  border-left: 5px solid #88b3ef;\n  border-radius: 8px;\n  padding: 10px 19px;\n  margin: 10px 0 14px 0;\n  color: #37465b;\n  font-size: 17px;\n}\n.drug-guide-note, .drug-guide-tip, .drug-guide-prompt, .drug-guide-em {\n  font-size: 16px;\n  margin-top: 12px;\n  margin-bottom: 6px;\n  color: #985623;\n  background: #fff7ea;\n  border-left: 4px solid #e4d187;\n  padding: 7px 14px;\n  border-radius: 6px;\n}\n.drug-guide-tip {\n  color: #2c6c6c;\n  background: #e7f5fe;\n  border-left-color: #8acade;\n}\n.drug-guide-prompt {\n  color: #385424;\n  background: #efefd7;\n  border-left-color: #a1ba80;\n}\n.drug-guide-em {\n  color: #ed3564;\n  background: #fff0f6;\n  border-left-color: #ec93ba;\n  font-weight: bold;\n}\n.drug-usage-list {\n  margin-left: 18px;\n  padding-left: 0;\n  color: #3c4b58;\n  font-size: 17px;\n  line-height: 1.8;\n}\n.drug-usage-list li {\n  margin-bottom: 9px;\n  list-style-type: decimal;\n}\n.drug-guide-bullet {\n  font-weight: bold;\n  color: #388cc7;\n  margin-right: 6px;\n}\n.drug-ref-list {\n  color: #544681;\n  font-size: 16px;\n  padding-left: 10px;\n  margin-bottom: 0;\n}\n@media (max-width:900px) {\n  .drug-section { margin: 20px 4% 22px 4%; padding: 18px 7px; font-size: 16px;}\n  .drug-section-title { font-size: 22px; padding: 10px 11px;}\n  .drug-point-block, .drug-side-block, .drug-summary-block { font-size: 15px; padding: 9px 6px;}\n}\n\u003C/style>","\u003Cdiv id=\"material_title\" class=\"drug-guide-title\">\n  \u003Ch1>胃癌T3N3M1期治疗常用药品安全用药指南\u003C/h1>\n  \u003Cp class=\"drug",507,"2025-12-02 00:52:32","胃癌, T3N3M1期, 化疗药, 安全用药, 不良反应, 错误用药, 免疫治疗, 药物相互作用, 老年患者用药","了解胃癌T3N3M1期治疗中化疗、靶向药和免疫药的安全用法。掌握用药注意事项、常见不良反应及禁忌高危人群信息，让您和家人更安心。","2025-12-31 22:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]